Linagliptin

[ customers have already purchased this product.]

Share |

Product name:Linagliptin

CAS:668270-12-0

Molecular formula:C25H28N8O2

Molecular weight:472.54

Product description:Linagliptin (BI-1356, trade names Tradjenta and Trajenta) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes.
Linagliptin (once-daily) was approved by the U.S. Food and Drug Administration (FDA) on 2 May 2011 for treatment of type II diabetes.

Please feel free to for: Linagliptin Quotation ( Linagliptin suppliers),COA (Certificate of Analysis), New Sales Promotion,New Products,And any other assistance.

<< 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-1h-(2R,3R)-1-(Dimethylamino)-3-(3-methoxyphenyl)-2-methylpentan-3-ol hydrochloride >>

Send to this supplier

After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@Greenstoneswiss.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6515 7632
4. Send enquiry online: